<DOC>
	<DOC>NCT01986322</DOC>
	<brief_summary>The main objective of this study was to evaluate the protectivity and safety of DTP/HB/Hib (Bio Farma) vaccine compared to DTP/HB and Hib vaccine given simultaneously.</brief_summary>
	<brief_title>Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine</brief_title>
	<detailed_description>This trial was randomized, single blind, prospective intervention study. Total 220 subject (6-11 weeks of ages) followed this trial, divided into 2 groups, each group consists of 110 subjects.</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Aluminum phosphate</mesh_term>
	<criteria>Infant 611 week of age Infant born after 3742 week of pregnancy Infant weighing more than 2.5 kg at birth Father, mother or legally acceptable representative properly informed about the study and having signed the informed consent form Parents commit themselves to comply with the indication of the investigator and with the schedule of the trial Mother at least graduate from elementary school Received Hepatitis B vaccine (Bio Farma) at birth Child concomitantly enroll or schedule to be enroll in another trial Evolving moderate or severe illness, especially infectious diseases or fever (axillary temperature &gt;=37.5 Celsius on Day 0) Known history of allergy to any component of the vaccine component (e.g.formaldehyde) History of uncontrolled coagulopathy or blood disorder contraindicating intramuscular injection Known history of congenital or acquired immunodeficiency (including HIV infection) Child who has received in the previous 4 weeks a treatment likely to alter the immune response (intravenous immunoglobulin, blood derived product or long term corticotherapy (&gt;2 weeks) Other vaccination within the 7 days prior to inclusion with the exception of BCG and poliomyelitis Any abnormality or chronic disease which according to the investigator might interfere with the assessment of the trial objective Infant with a known history of diphteria, tetanus, pertussis, Hib, Hepatitis B infection</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>11 Weeks</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>DTP/HB/Hib vaccine</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Infants</keyword>
	<keyword>Safety</keyword>
</DOC>